Literature DB >> 34157302

Expansion of tumor-associated Treg cells upon disruption of a CTLA-4-dependent feedback loop.

Francesco Marangoni1, Ademi Zhakyp2, Michela Corsini3, Shannon N Geels4, Esteban Carrizosa2, Martin Thelen3, Vinidhra Mani2, Jasper N Prüßmann2, Ross D Warner3, Aleksandra J Ozga2, Mauro Di Pilato2, Shivashankar Othy4, Thorsten R Mempel5.   

Abstract

Foxp3+ T regulatory (Treg) cells promote immunological tumor tolerance, but how their immune-suppressive function is regulated in the tumor microenvironment (TME) remains unknown. Here, we used intravital microscopy to characterize the cellular interactions that provide tumor-infiltrating Treg cells with critical activation signals. We found that the polyclonal Treg cell repertoire is pre-enriched to recognize antigens presented by tumor-associated conventional dendritic cells (cDCs). Unstable cDC contacts sufficed to sustain Treg cell function, whereas T helper cells were activated during stable interactions. Contact instability resulted from CTLA-4-dependent downregulation of co-stimulatory B7-family proteins on cDCs, mediated by Treg cells themselves. CTLA-4-blockade triggered CD28-dependent Treg cell hyper-proliferation in the TME, and concomitant Treg cell inactivation was required to achieve tumor rejection. Therefore, Treg cells self-regulate through a CTLA-4- and CD28-dependent feedback loop that adjusts their population size to the amount of local co-stimulation. Its disruption through CTLA-4-blockade may off-set therapeutic benefits in cancer patients.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD28; CTLA-4; MP-IVM; NFAT; T regulatory cell; Treg cell; cytotoxic T lymphocyte-associated protein 4; multiphoton intravital microscopy; nuclear factor of activated T cells; tumor tolerance

Mesh:

Substances:

Year:  2021        PMID: 34157302      PMCID: PMC8664158          DOI: 10.1016/j.cell.2021.05.027

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  100 in total

1.  Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength.

Authors:  Jackson G Egen; James P Allison
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

2.  T cell and APC dynamics in situ control the outcome of vaccination.

Authors:  Kamal M Khanna; David A Blair; Anthony T Vella; Stephen J McSorley; Sandip K Datta; Leo Lefrançois
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

3.  Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy.

Authors:  Stefani Spranger; Daisy Dai; Brendan Horton; Thomas F Gajewski
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

4.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

Review 5.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

6.  Feedback control of regulatory T cell homeostasis by dendritic cells in vivo.

Authors:  Guillaume Darrasse-Jèze; Stephanie Deroubaix; Hugo Mouquet; Gabriel D Victora; Thomas Eisenreich; Kai-hui Yao; Revati F Masilamani; Michael L Dustin; Alexander Rudensky; Kang Liu; Michel C Nussenzweig
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

7.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

8.  Immune homeostasis enforced by co-localized effector and regulatory T cells.

Authors:  Zhiduo Liu; Michael Y Gerner; Nicholas Van Panhuys; Andrew G Levine; Alexander Y Rudensky; Ronald N Germain
Journal:  Nature       Date:  2015-11-25       Impact factor: 49.962

9.  FOXP3 controls regulatory T cell function through cooperation with NFAT.

Authors:  Yongqing Wu; Madhuri Borde; Vigo Heissmeyer; Markus Feuerer; Ariya D Lapan; James C Stroud; Darren L Bates; Liang Guo; Aidong Han; Steven F Ziegler; Diane Mathis; Christophe Benoist; Lin Chen; Anjana Rao
Journal:  Cell       Date:  2006-07-28       Impact factor: 41.582

10.  Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma.

Authors:  John C Castle; Martin Loewer; Sebastian Boegel; Jos de Graaf; Christian Bender; Arbel D Tadmor; Valesca Boisguerin; Thomas Bukur; Patrick Sorn; Claudia Paret; Mustafa Diken; Sebastian Kreiter; Özlem Türeci; Ugur Sahin
Journal:  BMC Genomics       Date:  2014-03-13       Impact factor: 3.969

View more
  17 in total

Review 1.  Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment.

Authors:  Linqi Zhu; Yue Huang; Hong Li; Shihe Shao
Journal:  Appl Microbiol Biotechnol       Date:  2022-06-20       Impact factor: 4.813

2.  Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.

Authors:  Giacomo Oliveira; Kari Stromhaug; Nicoletta Cieri; J Bryan Iorgulescu; Susan Klaeger; Jacquelyn O Wolff; Suzanna Rachimi; Vipheaviny Chea; Kate Krause; Samuel S Freeman; Wandi Zhang; Shuqiang Li; David A Braun; Donna Neuberg; Steven A Carr; Kenneth J Livak; Dennie T Frederick; Edward F Fritsch; Megan Wind-Rotolo; Nir Hacohen; Moshe Sade-Feldman; Charles H Yoon; Derin B Keskin; Patrick A Ott; Scott J Rodig; Genevieve M Boland; Catherine J Wu
Journal:  Nature       Date:  2022-05-04       Impact factor: 49.962

Review 3.  Oxidative Stress in Cancer Immunotherapy: Molecular Mechanisms and Potential Applications.

Authors:  Ruolan Liu; Liyuan Peng; Li Zhou; Zhao Huang; Chengwei Zhou; Canhua Huang
Journal:  Antioxidants (Basel)       Date:  2022-04-27

Review 4.  Intravital and high-content multiplex imaging of the immune system.

Authors:  Jyh Liang Hor; Ronald N Germain
Journal:  Trends Cell Biol       Date:  2021-12-14       Impact factor: 21.167

Review 5.  Autoimmunity in motion: Mechanisms of immune regulation and destruction revealed by in vivo imaging.

Authors:  Jordan Jacobelli; Alan E Buser; Dustin L Heiden; Rachel S Friedman
Journal:  Immunol Rev       Date:  2021-11-25       Impact factor: 10.983

Review 6.  Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets.

Authors:  Yan Tie; Fan Tang; Yu-Quan Wei; Xia-Wei Wei
Journal:  J Hematol Oncol       Date:  2022-05-18       Impact factor: 23.168

Review 7.  Regulatory T Cells in Autoimmunity and Cancer: A Duplicitous Lifestyle.

Authors:  Aikaterini Hatzioannou; Athina Boumpas; Miranta Papadopoulou; Iosif Papafragkos; Athina Varveri; Themis Alissafi; Panayotis Verginis
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

Review 8.  Biomimetic and Materials-Potentiated Cell Engineering for Cancer Immunotherapy.

Authors:  Tingting Zhang; Yushan Yang; Li Huang; Ying Liu; Gaowei Chong; Weimin Yin; Haiqing Dong; Yan Li; Yongyong Li
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

Review 9.  Addressing the Elephant in the Immunotherapy Room: Effector T-Cell Priming versus Depletion of Regulatory T-Cells by Anti-CTLA-4 Therapy.

Authors:  Megan M Y Hong; Saman Maleki Vareki
Journal:  Cancers (Basel)       Date:  2022-03-20       Impact factor: 6.639

Review 10.  Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review).

Authors:  Wei Liang; Xinying He; Jianqiang Bi; Tingting Hu; Yunchuan Sun
Journal:  Oncol Rep       Date:  2021-07-30       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.